We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current HEB market cap is 86.55M. The company's latest EPS is USD -0.4044 and P/E is -4.45.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21k | 56k | 49k | 42k | 46k |
| Operating Income | -6.61M | -5.56M | -4.3M | -5.46M | -8.16M |
| Net Income | -6.39M | -4.39M | -3.66M | -4.91M | -7.82M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 367k | 140k | 163k | 135k | 141k |
| Operating Income | -11.5M | -12.44M | -15.02M | -17.06M | -19.92M |
| Net Income | -9.81M | -9.53M | -14.4M | -19.13M | -19.45M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.29M | 40.49M | 37.46M | 33.62M | 27.86M |
| Total Liabilities | 3.59M | 2.02M | 2.47M | 3.48M | 5.26M |
| Total Equity | 42.7M | 38.47M | 34.99M | 30.14M | 22.6M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.85M | 20.22M | 64.58M | 57.7M | 40.49M |
| Total Liabilities | 8.67M | 7.31M | 3.29M | 820k | 2.02M |
| Total Equity | 5.17M | 12.91M | 61.29M | 56.88M | 38.47M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -10.04M | -16.11M | -3.68M | -5.84M | -11.51M |
| Investing | 7.63M | 10.99M | -78k | -282k | -618k |
| Financing | 80k | 80k | 100k | 105k | 338k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -10.64M | -9.07M | -10.37M | -13.97M | -16.11M |
| Investing | 92k | -6.15M | -9.16M | -631k | 10.99M |
| Financing | 9.44M | 16.39M | 56.56M | 8.19M | 80k |
| Market Cap | 86.55M |
| Price to Earnings Ratio | -4.45 |
| Price to Sales Ratio | 620.69 |
| Price to Cash Ratio | 3.2 |
| Price to Book Ratio | 2.25 |
| Dividend Yield | - |
| Shares Outstanding | 48.08M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.2 (10.15%) |
| Company Name | Hemispherx Biopharma Inc New |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.aimimmuno.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
